What is Vitagene?
Vitagene operates in the direct-to-consumer health and wellness testing market, offering a suite of professional-grade diagnostic kits for at-home use. These tests provide individuals with actionable insights into crucial wellness metrics, including nutrition, sleep patterns, stress levels, and long-term health predispositions, all without requiring a doctor's consultation. The company's model emphasizes simplicity and accessibility, delivering clear instructions and easy-to-understand results directly to consumers, thereby empowering them to proactively manage their health.
How much funding has Vitagene raised?
Vitagene has raised a total of $5.7M across 2 funding rounds:
Angel/Seed
$5.5M
Debt
$150K
Angel/Seed (2016): $5.5M with participation from Viking Global Investors and Spectrum 28
Debt (2020): $150K led by PPP
Key Investors in Vitagene
Viking Global Investors
Viking Global Investors is a global investment firm known for its research-intensive approach to long-term investments in both public and private equity across diverse industries and geographies.
Spectrum 28
Spectrum 28 is a venture capital and private equity firm that invests in companies, likely focusing on high-growth potential businesses within its portfolio.
PPP
Public-Private Partnership
What's next for Vitagene?
The recent major strategic investment positions Vitagene for accelerated growth and market penetration. This capital infusion is likely to be directed towards enhancing its product development pipeline, expanding its testing capabilities, and scaling its operational infrastructure to meet increasing consumer demand. Furthermore, the strategic nature of the investment suggests potential collaborations or partnerships that could broaden Vitagene's reach and solidify its competitive advantage in the rapidly evolving personalized health landscape.
See full Vitagene company page
